187 related articles for article (PubMed ID: 31944864)
21. Novel mutations and a severe neurological phenotype in Sjögren-Larsson syndrome patients from Iran.
Kariminejad A; Barzgar M; Bozorgmehr B; Keshavarz E; Kariminejad MH; S'Aulis D; Rizzo WB
Eur J Med Genet; 2018 Mar; 61(3):139-144. PubMed ID: 29183715
[TBL] [Abstract][Full Text] [Related]
22. Sjögren-Larsson syndrome: optical coherence tomography and a novel mutation.
Burgueño-Montañés C; García-Fernández M; Colunga-Cueva M; García-López A
Arch Soc Esp Oftalmol; 2014 Dec; 89(12):504-7. PubMed ID: 24377952
[TBL] [Abstract][Full Text] [Related]
23. Phenotypic variability among adult siblings with Sjögren-Larsson syndrome.
Lossos A; Khoury M; Rizzo WB; Gomori JM; Banin E; Zlotogorski A; Jaber S; Abramsky O; Argov Z; Rosenmann H
Arch Neurol; 2006 Feb; 63(2):278-80. PubMed ID: 16476818
[TBL] [Abstract][Full Text] [Related]
24. Clinical, biochemical and molecular genetic characteristics of 19 patients with the Sjögren-Larsson syndrome.
Willemsen MA; IJlst L; Steijlen PM; Rotteveel JJ; de Jong JG; van Domburg PH; Mayatepek E; Gabreëls FJ; Wanders RJ
Brain; 2001 Jul; 124(Pt 7):1426-37. PubMed ID: 11408337
[TBL] [Abstract][Full Text] [Related]
25. Sjögren-Larsson syndrome: seven novel mutations in the fatty aldehyde dehydrogenase gene ALDH3A2.
Carney G; Wei S; Rizzo WB
Hum Mutat; 2004 Aug; 24(2):186. PubMed ID: 15241804
[TBL] [Abstract][Full Text] [Related]
26. Fatty aldehyde dehydrogenase: genomic structure, expression and mutation analysis in Sjögren-Larsson syndrome.
Rizzo WB; Lin Z; Carney G
Chem Biol Interact; 2001 Jan; 130-132(1-3):297-307. PubMed ID: 11306053
[TBL] [Abstract][Full Text] [Related]
27. [Sjögren-Larsson syndrome].
Möhrenschlager M; Rizzo WB; Kraus CS; Limbrock J; Cohen M; Anton-Lamprecht I; Abeck D; Ring J
Hautarzt; 2000 Apr; 51(4):250-5. PubMed ID: 10810660
[TBL] [Abstract][Full Text] [Related]
28. First prenatal diagnosis by mutation analysis in a family with Sjögren-Larsson syndrome.
Sillén A; Holmgren G; Wadelius C
Prenat Diagn; 1997 Dec; 17(12):1147-9. PubMed ID: 9467812
[TBL] [Abstract][Full Text] [Related]
29. Macular crystalline inclusions in Sjögren-Larsson syndrome are dynamic structures that undergo remodeling.
Al-Holou SN; Siefker E; Fouzdar-Jain S; Suh DW; Rizzo WB
Ophthalmic Genet; 2020 Aug; 41(4):381-385. PubMed ID: 32506993
[TBL] [Abstract][Full Text] [Related]
30. Restoration of fatty aldehyde dehydrogenase deficiency in Sjögren-Larsson syndrome.
Haug S; Braun-Falco M
Gene Ther; 2006 Jul; 13(13):1021-6. PubMed ID: 16525484
[TBL] [Abstract][Full Text] [Related]
31. Identification of Homozygous Likely Pathogenic Variant of ALDH3A2 in a Korean Boy with Sjögren-Larsson Syndrome.
Kim JY; Kim SH; Park MJ; Kim SH; Cho WH; Choi J; Ki CS; You SJ
Ann Lab Med; 2018 Jan; 38(1):80-82. PubMed ID: 29071827
[No Abstract] [Full Text] [Related]
32. A very rare neurocutaneous disorder in 2 siblings: Sjögren-Larsson syndrome.
Caglayan AO; Gumus H
J Child Neurol; 2010 Aug; 25(8):1003-5. PubMed ID: 20142464
[TBL] [Abstract][Full Text] [Related]
33. Ichthyosis in Sjögren-Larsson syndrome reflects defective barrier function due to abnormal lamellar body structure and secretion.
Rizzo WB; S'Aulis D; Jennings MA; Crumrine DA; Williams ML; Elias PM
Arch Dermatol Res; 2010 Aug; 302(6):443-51. PubMed ID: 20049467
[TBL] [Abstract][Full Text] [Related]
34. Sjögren-Larsson syndrome caused by novel mutations in ALDH3A2 gene.
Le NTA; Nguyen HLT; Trinh BN; Dang HH
Int J Dermatol; 2023 Jan; 62(1):e2-e4. PubMed ID: 36030534
[No Abstract] [Full Text] [Related]
35. Sjogren-Larsson syndrome associated hypermelanosis.
Xu YC; Hou JQ; Zhu WJ; Li P
J Cosmet Dermatol; 2020 Apr; 19(4):789-798. PubMed ID: 31697031
[TBL] [Abstract][Full Text] [Related]
36. A novel homozygous missense mutation in the fatty aldehyde dehydrogenase gene causes Sjögren-Larsson syndrome.
Nakano H; Akasaka E; Rokunohe D; Yokoyama S; Toyomaki Y; Umegaki N; Mitsuhashi Y; Sawamura D
J Dermatol Sci; 2008 Nov; 52(2):136-8. PubMed ID: 18684595
[No Abstract] [Full Text] [Related]
37. Novel ALDH3A2 mutations in structural and functional domains of FALDH causing diverse clinical phenotypes in Sjögren-Larsson syndrome patients.
Rajeshwari M; Karthi S; Singh R; Efthymiou S; Gowda VK; Varalakshmi P; Srinivasan VM; Houlden H; Keller MA; Rizzo WB; Ashokkumar B
Hum Mutat; 2021 Aug; 42(8):1015-1029. PubMed ID: 34082469
[TBL] [Abstract][Full Text] [Related]
38. A missense mutation in the FALDH gene identified in Sjögren-Larsson syndrome patients originating from the northern part of Sweden.
Sillén A; Jagell S; Wadelius C
Hum Genet; 1997 Aug; 100(2):201-3. PubMed ID: 9254849
[TBL] [Abstract][Full Text] [Related]
39. Sjögren-Larsson syndrome in Brazil is caused by a common c.1108-1G-->C splice-site mutation in the ALDH3A2 gene.
Auada MP; Puzzi MB; Cintra ML; Steiner CE; Alexandrino F; Sartorato EL; Aguiar TS; Azulay RD; Carney G; Rizzo WB
Br J Dermatol; 2006 Apr; 154(4):770-3. PubMed ID: 16536828
[No Abstract] [Full Text] [Related]
40. The molecular basis of Sjögren-Larsson syndrome: mutation analysis of the fatty aldehyde dehydrogenase gene.
Rizzo WB; Carney G; Lin Z
Am J Hum Genet; 1999 Dec; 65(6):1547-60. PubMed ID: 10577908
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
